Micronized dHACM vs. Saline in the Treatment of Osteoarthritis of the Knee



Status:Recruiting
Conditions:Arthritis, Osteoarthritis (OA)
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:21 - 80
Updated:12/5/2018
Start Date:March 27, 2018
End Date:December 2019
Contact:Stan Harris
Email:sharris@mimedx.com
Phone:770-651-9100

Use our guide to learn which trials are right for you!

A Phase 2B, Prospective, Double-blinded, Randomized Controlled Trial of the Micronized Dehydrated Human Amnion Chorion Membrane Injection as Compared to Saline Placebo Injection in the Treatment of Osteoarthritis of the Knee

The purpose of this study is to determine the safety and effectiveness of micronized
dehydrated human amnion chorion membrane as compared to the 0.9% Sodium Chloride Injection,
USP placebo control for the treatment of knee osteoarthritis


Inclusion Criteria:

1. Age ≥ 21 and ≤ 80 years

2. Subject has a diagnosis of osteoarthritis (OA) defined as Grade 1 to 3 on the Kellgren
Lawrence grading scale

3. Subject is willing and able provide informed consent and participate in all procedures
and follow-up evaluations necessary to complete the study

4. Subject must have a VAS pain scale greater than 45

Exclusion Criteria:

1. Subject has a diagnosis of osteoarthritis (OA) defined as Grade 4 on the Kellgren
Lawrence grading scale

2. BMI greater than 40 kg/m2

3. Subject has active infection at the injection site

4. Symptomatic OA of the contralateral knee or of either hip that is not responsive to
acetaminophen (Tylenol®) and requires other therapy.

5. Subject has rheumatoid arthritis, psoriatic arthritis, or have been diagnosed with any
other disorders that is the primary source of their knee pain, including but not
limited to: osteonecrosis, radiculopathy, bursitis, tendinitis, tumor, cancer

6. Subject has documented history of gout or pseudo-gout

7. Subject has autoimmune disease or a known history of having Acquired Immunodeficiency
Syndromes (AIDS) or HIV

8. Subject has received any of the following to the target knee:

1. Intra-articular hyaluronic acid (HA) injection within 12 weeks prior to screening

2. Steroid or platelet rich plasma (PRP) injection within 12 weeks prior to
screening

3. Has had or is planning to have major surgery or arthroscopy in the target knee
within 26 weeks of treatment

4. History of a total knee arthroplasty

9. Subject has used an investigational drug, device or biologic within 12 weeks prior to
treatment

10. Subject has a history of immunosuppressive or chemotherapy in the last 5 years

11. Subject has had prior radiation at the site

12. Subject is currently taking anticoagulant therapy (excluding Plavix or Aspirin)

13. Subject is pregnant or plans to become pregnant within 365 days of treatment

14. Subject has any significant medical condition that, in the opinion of the
Investigator, would interfere with protocol evaluation and participation

15. Subject is a worker's compensation patient

16. Subject is a prisoner
We found this trial at
9
sites
State College, Pennsylvania 16801
?
mi
from
State College, PA
Click here to add this to my saved trials
Altoona, Pennsylvania 16602
?
mi
from
Altoona, PA
Click here to add this to my saved trials
Ann Arbor, Michigan 48109
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
3280 Howell Mill Road Northwest
Atlanta, Georgia 30327
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Birmingham, Alabama 35205
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
Hinsdale, Illinois 60521
?
mi
from
Hinsdale, IL
Click here to add this to my saved trials
La Mesa, California 91942
?
mi
from
La Mesa, CA
Click here to add this to my saved trials
1115 Boulders Parkway
Richmond, Virginia 23235
?
mi
from
Richmond, VA
Click here to add this to my saved trials
Sarasota, Florida 34232
?
mi
from
Sarasota, FL
Click here to add this to my saved trials